Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:04 AM
Ignite Modification Date:
2025-12-25 @ 12:04 AM
NCT ID:
NCT03778658
Eligibility Criteria:
Inclusion Criteria:
* Participant age 15-21 years old at time of cancer diagnosis
* Participant diagnosis of cancer who is currently undergoing active treatment for cancer, or who is within 3 years of end of cancer treatment at the time of enrollment
* Participant receiving oncologic care at Penn State Health Children's Hospital or Penn State Cancer Institute
* Participant fluency in written and spoken English for participants \>= 18 years old
* Parent and participant fluency in written and spoken English for participants \< 18 years old
* Primary attending oncologist approval
* Participant must have access to a computer or smartphone
* Performance status of ECOG \<= 2, and Lansky /Karnofsky scale \>= 50
Exclusion Criteria:
* Cardiovascular or respiratory disease
* Class II, III or IV heart failure as defined by the New York Heart Association functional classification system
* History of acute coronary syndromes (including myocardial infarction and unstable angina), coronary angioplasty or stenting within the past 6 months prior to the start of chemotherapy
* Uncontrolled arrhythmias
* Syncope
* Acute myocarditis, pericarditis or endocarditis
* Diagnosed with pulmonary embolism or pulmonary infarction within 3 months of enrollment
* Diagnosed with deep venous thrombosis within 3 months of enrollment
* Any history of intracardiac thrombosis
* Suspected dissecting aneurysm
* Pulmonary edema
* Respiratory failure
* Acute non-cardiopulmonary disorder that may affect exercise performance or be exacerbated by physical activity
* Altered mental status or dementia
* Mental impairment leading to inability to cooperate
* Active bleeding
* Absolute contraindication to exercise
* Hemodynamic instability
* Pregnant women
* Non-English speaking
* Recent initiation of physical activity program within last 3 months
* Patients with relapsed cancer
* Patients who have undergone allogeneic stem cell transplant
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
15 Years
Study:
NCT03778658
Study Brief:
Protocol Section:
NCT03778658